The effect of medical innovation on the cost-effectiveness of Covid 19-related policies in the United States using a SIR model
Abstract Background During 2020–21, the United States used a multifaceted approach to control SARS-CoV-2 (Covid-19) and reduce mortality and morbidity. This included non-medical interventions (NMIs), aggressive vaccine development and deployment, and research into more effective approaches to medica...
Main Authors: | Adam J. Atherly, Eline M. van den Broek-Altenburg |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2023-04-01
|
Series: | BMC Health Services Research |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12913-023-09282-1 |
Similar Items
-
Universal Dental Adhesives: Cost-Effectiveness and Duration of Use
by: Ayman A. Banjar, et al.
Published: (2022-01-01) -
Intensive care unit mortality and cost-effectiveness associated with intensivist staffing: a Japanese nationwide observational study
by: Saori Ikumi, et al.
Published: (2023-12-01) -
Cost–Effectiveness Analysis of Pharmacist Adherence Interventions in People Living with HIV/AIDS in Pakistan
by: Ali Ahmed, et al.
Published: (2023-09-01) -
Cost-effectiveness of different human papillomavirus vaccines in Singapore
by: Tay Sun, et al.
Published: (2011-03-01) -
Cost-effectiveness of treatment in adults with blood pressure of 130–139/80–89 mmHg and high cardiovascular risk in China: a modelling studyResearch in context
by: Jiangtao Li, et al.
Published: (2024-01-01)